News

Nexus Aortic Arch System Artivion Endospan

The purchase price could end up being closer to $200 million if certain commercial milestones are met.

Ziad Ali, MD, DPhil, director of the DeMatteis Cardiovascular Institute, St. Francis Hospital and Heart Center, spoke with Cardiovascular Business about his center's experience using the recently released Johnson & Johnson MedTech next-generation Shockwave C2 Aero Coronary IVL Catheter to treat calcified coronary artery disease. Ali said his center was the first in the world to use the catheter in August 2025 and has since gained experience in roughly 80 cases.

Ziad Ali, MD, said the new device has completely changed the way he and his colleagues treat patients with calcified coronary artery disease. 

Medtronic Evolut FX TAVR valve

These three-year data represent a major update to one of the more noteworthy TAVR trials in recent memory.

Thumbnail

The country’s largest independent imaging group—located in Fort Worth and employing about 300 physicians—calculated the figure based on an internal analysis of its billing practices. 

Thumbnail

“Hassle factor” and the profession being “too stressful” were among the top 2 reasons for exiting practice, according to new survey data from the AMA.

court brain scan legal gavel lawsuit malpractice judge

Jeffrey and Kim Sayward, of Florida, charge that radiologist Eric J. Sax, MD, working for MaineHealth Hospital in Biddeford at the time, failed to identify a dangerous blood clot three years ago. 

pregnancy mother to be

Washington-based Providence Health and Services denies the allegations. The lawsuit, filed by the state attorney general, details incidents of noncompliance and retaliation dating back to 2021. 

robotic PCI Corindus CorPath GRX

Researchers reviewed years of data from two different Corindus systems, highlighting the consistently high clinical and technical success rates.

GE Healthcare's CleaRecon DL reduces IR image artifacts during procedures

Clinical validation testing proved CleaRecon DL’s 3D image reconstructions to be effective at reducing unwanted artifacts, offering clearer images in 98% of cases.

Gerald Blackwell, president and CEO of MedAxiom, discusses the business of cardiology at ACC 2025.

Gerald G. Blackwell, MD, MBA, MedAxiom's president and CEO, examined how different cardiology employment models look today compared to even a decade ago.

robot reviewing heart data

Researchers have used a state-of-the-art microscope and advanced AI to track clotting risks in CAD patients. The goal is to spot blood clots before they even happen, ensuring patients are prescribed the right therapy for their specific needs. 

Around the web

The purchase price could end up being closer to $200 million if certain commercial milestones are met.

Ziad Ali, MD, said the new device has completely changed the way he and his colleagues treat patients with calcified coronary artery disease.